News
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug approvals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback